Blood cell study may personalize asthma and sinusitis treatment
NCT ID NCT04187976
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at different types of immune cells (eosinophils) in the blood of people with asthma, chronic sinusitis with nasal polyps, or both, compared to healthy volunteers. The goal was to find patterns that could help doctors choose the best targeted therapy for each patient. The study involved 70 participants and has already been completed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors choose the right biologic treatment for patients with asthma or sinusitis based on their specific immune profile.
- What could go wrong
- This is a small, completed observational study, not a treatment trial. The findings may not lead to immediate changes in care or apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SINUSITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Lille
Lille, 59000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a drug that calms inflammation ease chronic sinusitis?
- Smart inhalers track Fasenra's asthma control over full dosing cycle
- Withdrawn study sought to understand sinus problems in young cancer survivors
- Gentle Hands-On therapy shows promise for sinus sufferers
- Asthma Drug's gene secrets revealed in small study
- New sinus implant aims to unblock noses and ease facial pain